NDC 86119-200 - Euthanasia Solution
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86119-200
- Package NDCs from labels
- 86119-200-05
- Manufacturer
- Noble Pharma, LLC
- Effective date
- 2026-02-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Euthanasia Solution - Noble Pharma, LLC | Noble Pharma, LLC | 2026-02-09 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86119-200-05 | Euthanasia Solution | 100 mL in 1 VIAL, MULTI-DOSE | SOLUTION | 100 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Phenytoin Sodium | PHENYTOIN SODIUM | Aphena Pharma Solutions - Tennessee, LLC | 29b8d0a2-a96e-46a5-e063-6394a90a7113 | 2024-12-20 | Warnings, Adverse reactions | 4182431BJH |
| Extended Phenytoin Sodium | PHENYTOIN SODIUM | NCS HealthCare of KY, LLC dba Vangard Labs | a7bfb3aa-5226-4a48-8156-a9ecc4536fdf | 2024-10-18 | Warnings, Adverse reactions | 4182431BJH |
| Phenytek | EXTENDED PHENYTOIN SODIUM | Mylan Pharmaceuticals Inc. | 0f94c791-8b07-4b41-927e-c9f28bec5f60 | 2024-10-15 | Warnings, Adverse reactions | 4182431BJH |
| PHENYTOIN SODIUM | PHENYTOIN SODIUM | Acella Pharmaceuticals, LLC | 6922f32f-8bed-4c09-8103-27987bcbd104 | 2024-09-16 | Boxed warning, Warnings, Adverse reactions | 4182431BJH |
| Phenytoin Sodium | PHENYTOIN SODIUM | A-S Medication Solutions | d4459837-da26-4c97-8587-32eb1f682d58 | 2024-05-22 | Warnings, Adverse reactions | 4182431BJH |
| Phenytoin Sodium | PHENYTOIN SODIUM | Hikma Pharmaceuticals USA Inc. | 035a8d4e-2063-4240-83cb-d7eebcabe301 | 2024-04-09 | Boxed warning, Warnings, Adverse reactions | 4182431BJH |
| Phenytoin Sodium | PHENYTOIN SODIUM | Hikma Pharmaceuticals USA Inc. | 8ad1be7b-a1a4-4a2a-bf9b-d22b350aa6e7 | 2024-04-09 | Boxed warning, Warnings, Adverse reactions | 4182431BJH |
| Pentobarbital Sodium | PENTOBARBITAL SODIUM | Hikma Pharmaceuticals USA Inc. | d375b92a-baa1-4d63-9ad1-1467dcfde7d5 | 2024-03-08 | Warnings, Adverse reactions | NJJ0475N0S |
| PHENYTOIN SODIUM | PHENYTOIN SODIUM | HF Acquisition Co LLC, DBA HealthFirst | 7607ddff-2f1c-272c-e053-2991aa0a1ab3 | 2024-01-22 | Boxed warning, Warnings, Adverse reactions | 4182431BJH |
| Phenytoin Sodium | PHENYTOIN SODIUM | Medical Purchasing Solutions, LLC | 0aac9dcd-c4df-84d9-e063-6294a90a0376 | 2023-11-21 | Boxed warning, Warnings, Adverse reactions | 4182431BJH |
| Extended Phenytoin Sodium | PHENYTOIN SODIUM | Aurobindo Pharma Limited | 5362ea50-38a4-48b4-a85b-d634c3d8b91a | 2023-09-21 | Warnings, Adverse reactions | 4182431BJH |
| DILANTIN | EXTENDED PHENYTOIN SODIUM | Viatris Specialty LLC | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 2023-08-21 | Warnings, Adverse reactions | 4182431BJH |
| phenytoin sodium | PHENYTOIN SODIUM | Sun Pharmaceutical Industries, Inc. | c40f66cc-6f4a-4b29-84ba-d265e4848735 | 2022-12-14 | Warnings, Adverse reactions | 4182431BJH |
| PHENYTOIN SODIUM | PHENYTOIN SODIUM | HF Acquisition Co LLC, DBA HealthFirst | 763b549d-9b78-09dd-e053-2a91aa0aec7f | 2022-12-09 | Boxed warning, Warnings, Adverse reactions | 4182431BJH |
| Phenytoin Sodium | PHENYTOIN SODIUM | Unichem Pharmaceuticals (USA), Inc. | afdf66e0-5f99-444e-bc06-2fdddc507f5c | 2022-10-19 | Warnings, Adverse reactions | 4182431BJH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.